• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性高血压的利尿治疗

Diuretic treatment of resistant hypertension.

作者信息

Ramsay L E, Silas J H, Freestone S

出版信息

Br Med J. 1980 Oct 25;281(6248):1101-3. doi: 10.1136/bmj.281.6248.1101.

DOI:10.1136/bmj.281.6248.1101
PMID:7427599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1714545/
Abstract

In patients with hypertension resistant to three or four drugs including a thiazide diuretic substitution of frusemide for the thiazide, or the addition of spironolactone, produced significant reductions in blood pressure and body weight. The response did not depend on the presence of overt fluid retention, renal impairment, or the use of antihypertensive drugs of high potency. Women had larger responses than men. Expansion of the plasma or extracellular fluid volume is an important cause of resistance to treatment even when a thiazide diuretic is used. An increase in diuretic treatment should be tried before using the postganglionic adrenergic blockers or minoxidil in resistant hypertension.

摘要

在使用包括噻嗪类利尿剂在内的三到四种药物治疗仍耐药的高血压患者中,用呋塞米替代噻嗪类利尿剂,或加用螺内酯,可使血压和体重显著降低。这种反应不取决于是否存在明显的液体潴留、肾功能损害或使用高效能抗高血压药物。女性的反应比男性更明显。即使使用噻嗪类利尿剂,血浆或细胞外液容量的增加也是治疗耐药的一个重要原因。在耐药性高血压中,在使用节后肾上腺素能阻滞剂或米诺地尔之前,应尝试增加利尿剂治疗。

相似文献

1
Diuretic treatment of resistant hypertension.顽固性高血压的利尿治疗
Br Med J. 1980 Oct 25;281(6248):1101-3. doi: 10.1136/bmj.281.6248.1101.
2
Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?顽固性高血压的管理:醛固酮拮抗剂还是强化利尿治疗?
Nephrology (Carlton). 2015 Aug;20(8):567-71. doi: 10.1111/nep.12475.
3
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.螺内酯、氨氯吡咪、氯沙坦与噻嗪类药物(SALT)对低肾素性高血压和醛固酮-肾素比值升高患者的双盲交叉试验。
Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.
4
[Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].[原发性高血压患者使用利尿剂治疗期间血压、血容量与血浆肾素之间的相关性。盐皮质激素拮抗剂螺内酯与“袢”利尿剂美夫西特的比较]
Schweiz Med Wochenschr. 1977 Jan 29;107(4):104-15.
5
Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.替尼酸、苄氟噻嗪和螺内酯的利钠、促尿酸排泄及降压特性比较。
Br Med J. 1979 Jan 27;1(6158):224-6. doi: 10.1136/bmj.1.6158.224.
6
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.“第三种药物”试验:当血压在β受体阻滞剂加噻嗪类利尿剂治疗下仍未得到控制时,添加抗高血压药物的比较研究。
Br Med J (Clin Res Ed). 1984 Jan 14;288(6411):106-11. doi: 10.1136/bmj.288.6411.106.
7
The rational use of diuretics in the treatment of arterial hypertension.利尿剂在动脉高血压治疗中的合理应用。
Angiology. 1976 Jun;27(6):358-69. doi: 10.1177/000331977602700604.
8
The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic.“第三种药物”试验:当β受体阻滞剂加噻嗪类利尿剂无法控制血压时添加抗高血压药物的比较研究。
J Hypertens Suppl. 1983 Dec;1(2):116-9.
9
An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.一项开放性平行组研究,比较速尿/阿米洛利利尿剂与含环戊噻嗪及缓释钾的利尿剂在治疗充血性心力衰竭中的效果——一项多中心全科医疗研究。
J Int Med Res. 1990;18 Suppl 2:17B-23B.
10
Trends in Antihypertensive Medication Use Among US Patients With Resistant Hypertension, 2008 to 2014.2008年至2014年美国顽固性高血压患者的抗高血压药物使用趋势
Hypertension. 2016 Dec;68(6):1349-1354. doi: 10.1161/HYPERTENSIONAHA.116.08128. Epub 2016 Oct 24.

引用本文的文献

1
Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis.高血压与骨关节炎——重新审视血管发病假说。
Nat Rev Rheumatol. 2021 Sep;17(9):533-549. doi: 10.1038/s41584-021-00650-x. Epub 2021 Jul 27.
2
Loop Diuretics in the Treatment of Hypertension.襻利尿剂在高血压治疗中的应用
Curr Hypertens Rep. 2016 Apr;18(4):27. doi: 10.1007/s11906-016-0636-7.
3
Individualizing antihypertensive combination therapies: clinical and hemodynamic considerations.个体化抗高血压联合治疗:临床及血流动力学考量
Curr Hypertens Rep. 2014 Jul;16(7):451. doi: 10.1007/s11906-014-0451-y.
4
Common secondary causes of resistant hypertension and rational for treatment.难治性高血压的常见继发性病因及治疗依据。
Int J Hypertens. 2011 Mar 2;2011:236239. doi: 10.4061/2011/236239.
5
The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.醛固酮在顽固性高血压中的作用:对发病机制和治疗的启示。
Curr Hypertens Rep. 2007 Apr;9(2):98-105. doi: 10.1007/s11906-007-0018-2.
6
Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.低剂量醛固酮阻断作为控制顽固性高血压的新治疗模式。
J Clin Hypertens (Greenwich). 2007 Jan;9(1 Suppl 1):19-24. doi: 10.1111/j.1524-6175.2007.06334.x.
7
Spironolactone: an old friend rediscovered.螺内酯:一位被重新发现的老朋友。
J Clin Hypertens (Greenwich). 2006 Jul;8(7):467-9. doi: 10.1111/j.1524-6175.2006.05155.x.
8
Treatment of resistant hypertension.
Curr Hypertens Rep. 2005 Oct;7(5):323-9. doi: 10.1007/s11906-005-0064-6.
9
Preliminary evaluation of pinacidil in hypertension.匹那地尔治疗高血压的初步评估。
Br J Clin Pharmacol. 1983 Sep;16(3):336-8. doi: 10.1111/j.1365-2125.1983.tb02171.x.
10
Modern diuretic treatment.现代利尿治疗。
Br Med J (Clin Res Ed). 1983 Apr 30;286(6375):1419-22. doi: 10.1136/bmj.286.6375.1419.

本文引用的文献

1
CLINICAL FEATURES OF FLUID RETENTION COMPLICATING TREATMENT WITH GUANETHIDINE.胍乙啶治疗引发液体潴留的临床特征
Circulation. 1965 Apr;31:485-9. doi: 10.1161/01.cir.31.4.485.
2
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.氨氯吡咪、螺内酯及氯化钾用于噻嗪类药物治疗的高血压患者
Clin Pharmacol Ther. 1980 Apr;27(4):533-43. doi: 10.1038/clpt.1980.75.
3
Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient.
Am Heart J. 1971 Apr;81(4):563-5. doi: 10.1016/0002-8703(71)90374-7.
4
Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
N Engl J Med. 1972 Apr 20;286(16):861-6. doi: 10.1056/NEJM197204202861603.
5
Diuretic and diet treatment of hypertension.高血压的利尿及饮食治疗
Arch Intern Med. 1974 Jun;133(6):1007-13.
6
Large dose furosemide therapy for hypertension. Long-term use in 22 patients.
Am J Cardiol. 1974 Apr;33(4):546-9. doi: 10.1016/0002-9149(74)90615-8.
7
Drug combinations as rational antihypertensive therapy.作为合理降压治疗的联合用药
Arch Intern Med. 1974 Jun;133(6):1053-7.
8
Drugs in the management of hypertension. Part I.
Am Heart J. 1976 Jun;91(6):810-5. doi: 10.1016/s0002-8703(76)80548-0.
9
A role of frusemide in resistant hypertension.
Med J Aust. 1977 Feb 12;1(7):213-5. doi: 10.5694/j.1326-5377.1977.tb130634.x.
10
Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics.三联药物治疗难治性原发性高血压:一项关于中心和外周血流动力学的研究
Circulation. 1978 Oct;58(4):615-22. doi: 10.1161/01.cir.58.4.615.